FDA Approved: ASMANEX HFA — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental NDA for ASMANEX HFA (mometasone furoate) from Organon LLC, authorizing changes via a supplemental application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• ASMANEX HFA (mometasone furoate)

Snippet

SUPPL AP for ASMANEX HFA (MOMETASONE FUROATE)